Margaret A. Baird

2.4k total citations
71 papers, 1.8k citations indexed

About

Margaret A. Baird is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Margaret A. Baird has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 17 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Margaret A. Baird's work include Immunotherapy and Immune Responses (33 papers), Virus-based gene therapy research (13 papers) and T-cell and B-cell Immunology (13 papers). Margaret A. Baird is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Virus-based gene therapy research (13 papers) and T-cell and B-cell Immunology (13 papers). Margaret A. Baird collaborates with scholars based in New Zealand, Australia and United States. Margaret A. Baird's co-authors include Vernon K. Ward, Sarah L. Young, Michelle Wilson, Gerald W. Tannock, Thomas Rades, Nigel Davies, Sarah Wilson, G.S. Buchan, Diane M. Loach and Megan Livingston and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Margaret A. Baird

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret A. Baird New Zealand 25 786 766 277 260 258 71 1.8k
Jannet Katz United States 27 664 0.8× 900 1.2× 254 0.9× 91 0.3× 252 1.0× 46 2.2k
R Audran Switzerland 21 877 1.1× 928 1.2× 385 1.4× 101 0.4× 325 1.3× 63 2.5k
Sven C. M. Bruijns Netherlands 24 1.1k 1.4× 1.2k 1.5× 272 1.0× 181 0.7× 240 0.9× 38 2.2k
Sarah S. Wilson United States 18 805 1.0× 391 0.5× 222 0.8× 175 0.7× 376 1.5× 24 1.7k
Barbara Valzasina Italy 10 871 1.1× 2.3k 3.0× 312 1.1× 577 2.2× 217 0.8× 11 3.5k
Edward T. Lally United States 35 1.1k 1.5× 783 1.0× 195 0.7× 148 0.6× 363 1.4× 85 3.7k
Ulf Yrlid Sweden 30 540 0.7× 2.0k 2.7× 377 1.4× 272 1.0× 202 0.8× 63 2.8k
Matteo Urbano Italy 10 720 0.9× 1.2k 1.6× 320 1.2× 69 0.3× 209 0.8× 10 2.2k
Martin J. Pearse Australia 36 1.2k 1.5× 1.3k 1.8× 261 0.9× 251 1.0× 532 2.1× 98 3.7k
Kristina Eriksson Sweden 22 604 0.8× 1.1k 1.4× 281 1.0× 170 0.7× 512 2.0× 39 2.1k

Countries citing papers authored by Margaret A. Baird

Since Specialization
Citations

This map shows the geographic impact of Margaret A. Baird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret A. Baird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret A. Baird more than expected).

Fields of papers citing papers by Margaret A. Baird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret A. Baird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret A. Baird. The network helps show where Margaret A. Baird may publish in the future.

Co-authorship network of co-authors of Margaret A. Baird

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret A. Baird. A scholar is included among the top collaborators of Margaret A. Baird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret A. Baird. Margaret A. Baird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Sunali, Grégory Gimenez, Hamish G. Campbell, et al.. (2019). The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer. Cell Death and Disease. 10(9). 631–631. 32 indexed citations
2.
Aschner, Clare Burn, Michelle Wilson, Kévin Ly, et al.. (2018). Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response. Scientific Reports. 8(1). 2373–2373. 16 indexed citations
3.
Hung, Noelyn, Sunali Mehta, Alison M. Rich, et al.. (2017). Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression. Scientific Reports. 7(1). 1566–1566. 8 indexed citations
4.
Li, Kunyu, Margaret A. Baird, Jianping Yang, et al.. (2016). Conditions for the generation of cytotoxic CD4+ Th cells that enhance CD8+ CTL‐mediated tumor regression. Clinical & Translational Immunology. 5(8). e95–e95. 11 indexed citations
5.
Campbell, Heather, Claire Vennin, Michelle Wilson, et al.. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene. 35(38). 4981–4989. 30 indexed citations
6.
Campbell, Hamish G., Reena Mehta, Axel A. Neumann, et al.. (2012). Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD). Oncogene. 32(7). 827–836. 14 indexed citations
7.
Li, Kunyu, Michelle Wilson, Vivienne L. Young, et al.. (2012). Antigen Incorporated In Virus-like Particles Is Delivered to Specific Dendritic Cell Subsets That Induce An Effective Antitumor Immune Response In Vivo. Journal of Immunotherapy. 36(1). 11–19. 26 indexed citations
8.
Campbell, Hamish G., Tania L. Slatter, Aaron Jeffs, et al.. (2012). Does Δ133p53 isoform trigger inflammation and autoimmunity?. Cell Cycle. 11(3). 446–450. 21 indexed citations
9.
Ward, Vernon K., et al.. (2011). Cross‐presentation of epitopes on virus‐like particles via the MHC I receptor recycling pathway. Immunology and Cell Biology. 89(6). 681–688. 71 indexed citations
10.
Slatter, Tania L., Reena Mehta, Carlos Rubio-Terrés, et al.. (2009). p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death and Differentiation. 17(3). 540–550. 31 indexed citations
11.
Peacey, Matthew, Sarah Wilson, Rachel Perret, et al.. (2008). Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response. Vaccine. 26(42). 5334–5337. 33 indexed citations
12.
Peacey, Matthew, Sarah Wilson, Margaret A. Baird, & Vernon K. Ward. (2007). Versatile RHDV virus‐like particles: Incorporation of antigens by genetic modification and chemical conjugation. Biotechnology and Bioengineering. 98(5). 968–977. 63 indexed citations
13.
Young, Sarah L., Michelle Wilson, Sarah Wilson, et al.. (2006). Transcutaneous vaccination with virus-like particles. Vaccine. 24(26). 5406–5412. 25 indexed citations
14.
Baird, Margaret A., Rachel Wilson, Louise J. Young, et al.. (2004). Bystander Help within a Polyepitope DNA Vaccine Improves Immune Responses to Influenza Antigens. Scandinavian Journal of Immunology. 60(4). 363–371. 11 indexed citations
15.
Baird, Margaret A., Thomas Rades, Judith L. McKenzie, et al.. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine. 21(9-10). 883–890. 142 indexed citations
16.
Faulkner, Lee, Glenn Buchan, Euan Lockhart, et al.. (2001). IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells. International Immunology. 13(6). 713–721. 20 indexed citations
17.
Faulkner, L, G.S. Buchan, & Margaret A. Baird. (2000). Interleukin‐10 does not affect phagocytosis of particulate antigen by bonemarrow‐derived dendritic cells but does impair antigen presentation. Immunology. 99(4). 523–531. 55 indexed citations
18.
Buchan, G.S., Sarah L. Young, Euan Lockhart, et al.. (2000). Targeting early events in T cell activation to construct improved vaccines. Molecular Immunology. 37(9). 545–552. 5 indexed citations
19.
Baird, Margaret A.. (1994). POSTCODE 3000. Australian Planner. 31(3). 153–158. 1 indexed citations
20.
Heslop, Barbara F., Mark Bradley, & Margaret A. Baird. (1989). A proposed growth regulatory function for the serologically detectable sex-specific antigen H-Ys. Human Genetics. 81(2). 99–104. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jannet Katz Breakdown of academic impact, for papers by R Audran Breakdown of academic impact, for papers by Sven C. M. Bruijns Breakdown of academic impact, for papers by Sarah S. Wilson Breakdown of academic impact, for papers by Barbara Valzasina Breakdown of academic impact, for papers by Edward T. Lally Breakdown of academic impact, for papers by Ulf Yrlid Breakdown of academic impact, for papers by Matteo Urbano Breakdown of academic impact, for papers by Martin J. Pearse Breakdown of academic impact, for papers by Kristina Eriksson
Rankless by CCL
2026